TriSalus Life Sciences, Inc. (TLSI) has reported a widened loss for its first quarter compared to the same period last year.
The company's net loss was $14.020 million, or $0.60 per share, compared to a loss of $9.227 million, or $0.57 per share, in the first quarter of the previous year.
However, the company's revenue for the quarter saw a significant increase of 116.4%, rising to $6.457 million from $2.984 million the previous year.
Here is a summary of TriSalus Life Sciences, Inc.'s first-quarter earnings (GAAP):
- Net Loss (Q1): $14.020 million, compared to $9.227 million last year.
- Earnings Per Share (EPS) (Q1): -$0.60, compared to -$0.57 last year.
- Revenue (Q1): $6.457 million, compared to $2.984 million last year.
